Dr. Jan Engels
Senior Investment Manager
About me
| Team | Life Sciences & Chemistry |
| at HTGF since | 2022 |
CV
Following a bachelor’s degree in biotechnology, Dr. Jan F. Engels completed a PhD in chemistry and nanotechnology in Hong Kong, where he stayed the past 10 years. During his PhD studies he co-founded a medical device start-up in the field of ophthalmology and drug delivery with the position as VP technology. Next to R&D, his focus was on technology patents and business development with successful collaborations with listed companies in US, Europe, and Japan. Next to his start-up position, Jan has a part time lecturer position, teaching Entrepreneurship. After returning to Germany, he joined High-Tech Gründerfonds as an Investment Manager Life Science.
My success stories in the HTGF portfolio
Symphera is a Munich-based startup that is revolutionizing laparoscopic surgery with an innovative system designed to eliminate the need for manual instrument changes. Founded in 2023, Symphera was incubated at …
to Symphera
Sedivention is developing a medical device for a new therapy of obesity. The Blizzard cryocatheter freezes the nerve branches, that transmit an increased, inadequate feeling of hunger to the brain …
to Sedivention
Skinuvita is a digital care model for the home use of phototherapy for chronic skin conditions such as psoriasis and neurodermatitis. With the innovative telemedicine system, the prescribed dose is …
to Skinuvita
CustomSurg, founded in 2021, is a Spin-Off from ETH Zurich and Harvard University. The company is developing software-as-a-medical-device (SaMD) solutions for the optimal selection and placement of orthopaedic implants in …
to CustomSurg
MDTB stands for drugs, which are based on the immunomodulating drug substance Desacell®. Desacell® is an advanced drug platform based on MSC (Mesenchymal Stromal Cells) and addresses many inflammatory-associated diseases …
to MDTB Cell Manufacturing
The company was founded in 2022 and is headquartered at the STIMULATE research campus in Magdeburg’s “science-harbour”. The scientific company is a spin-off by scientists from the Otto-von-Guericke-University Magdeburg. The …
to RAYDIAX
ReCatalyst is on a mission to revolutionize the proton exchange membrane fuel cell industry by providing customizable next-generation platinum-alloy catalyst solutions. Our primary focus is to enable the massive scalability …
to ReCatalyst
Mbiomics is a Munich based microbiome startup company which was founded by Dr. Laura Figulla (CEO), Dr. Johannes Wöhrstein (CTO), and Dr. Markus Rinecker (CMO) in 2020. With its proprietary …
to mbiomics
Refined Laser Systems GmbH, based in Münster, Germany, was founded in 2019 as a spin-off from University of Münster by Max Brinkmann, Tim Hellwig and Christoph Seidenstücker. The company’s core …
to Refined Laser Systems
IOP GmbH will initiate a paradigm chance in glaucoma therapy by its products for telemetric, 24 hour monitoring of intraocular pressure, allowing personalized patient management.
to Implandata Ophthalmic Products
Guided to exit
Exit
GME German Medical Engineering develops and markets a new generation of laser and lightsystems (small, light weight, modular) for the use in cosmetic and medical dermatology.
to GME
Recent posts
Zum Artikel
Social Media & contact
LinkedIn
Dr. Jan Engels
Profil